Xinhua Finance | 131 STAR Market Listed Companies Publish Annual Reports; Aggregate Net Profit Rises 49% Year-on-Year

As of March 31, 131 companies listed on the STAR Market have disclosed their annual reports, with combined operating revenue reaching RMB 584.9 billion and combined net profit RMB 47.3 billion, up 18% and 49% year-on-year respectively. In terms of dividend distribution, the 131 companies paid a total cash dividend of RMB 14.614 billion, a year-on-year increase of 8%; among them, 71 companies recorded a dividend payout ratio higher than 30%.

Xinhua Finance, March 31, Shanghai (Reporter: Du Kang) — As of March 31, 131 STAR Market listed companies have released their annual reports, posting total operating revenue of RMB 584.9 billion and total net profit of RMB 47.3 billion, representing a year-on-year growth of 18% and 49% respectively. In respect of dividends, the aggregate cash dividends distributed by the 131 companies stood at RMB 14.614 billion, an 8% year-on-year increase. Among them, 71 companies achieved a dividend payout ratio exceeding 30%. China Railway Signal & Communication Corporation, Shenzhen Transsion Holdings and Zhuzhou CRRC Times Electric distributed cash dividends of RMB 1.8 billion, RMB 1.036 billion and RMB 923 million respectively.

In terms of performance highlights, Advanced Micro-Fabrication Equipment Inc. China (AMEC) maintained its leading edge in MOCVD equipment and delivered solid achievements in new product development, with operating revenue hitting RMB 12.385 billion and net profit RMB 2.111 billion, up 37% and 31% year-on-year, respectively. Montage Technology registered a marked growth in shipments of interconnection chips, securing operating revenue of RMB 5.456 billion and net profit of RMB 2.236 billion, a year-on-year increase of 50% and 58%, respectively. Verisilicon Microelectronics saw a sharp surge in newly signed orders in AI computing power and data processing, achieving operating revenue of RMB 3.152 billion, up 36% year-on-year. Ninebot continued to deepen its strategic layout in two core businesses: intelligent short-distance mobility and service robots, with operating revenue and net profit reaching RMB 21.3 billion and RMB 1.8 billion respectively, rising 50% and 62% year-on-year, respectively. Among innovative drug enterprises, Sunshine Guojian achieved a 317% year-on-year jump in net profit driven by BD transactions; Dizal Pharma-U recorded a 123% year-on-year growth in operating revenue bolstered by rising product sales volume.